Livermore, CA, United States of America

Todd Zachary Desantis

USPTO Granted Patents = 2 

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2019-2023

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Todd Zachary Desantis: Innovator in Therapeutic Proteins

Introduction

Todd Zachary Desantis is a notable inventor based in Livermore, CA (US). He has made significant contributions to the field of therapeutic proteins, particularly in the treatment of gastrointestinal disorders. With a total of 2 patents, his work focuses on enhancing epithelial barrier function.

Latest Patents

Desantis's latest patents include innovative therapeutic proteins aimed at treating epithelial barrier function disorders. These proteins and their pharmaceutical compositions are designed to address various human diseases, especially gastrointestinal inflammatory diseases. His research specifically targets conditions associated with decreased epithelial cell barrier function, including inflammatory bowel diseases such as Crohn's disease and ulcerative colitis.

Career Highlights

Todd Zachary Desantis is currently associated with Second Genome, Inc., where he continues to advance his research in therapeutic proteins. His work has the potential to significantly impact the treatment of gastrointestinal conditions, improving the quality of life for many patients.

Collaborations

Desantis collaborates with talented individuals in his field, including Andrew Wonhee Han and Andrew Whitman Goodyear. These partnerships enhance the innovative capacity of his research and development efforts.

Conclusion

Todd Zachary Desantis is a prominent figure in the field of therapeutic proteins, with a focus on treating gastrointestinal disorders. His contributions through his patents and collaborations are paving the way for advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…